Skip to main content

Tweets

Dr. R Landewe highlights #EULAR2020 #COVID19 Guidelines: 1. RMD-patients do NOT have higher risk for complications 2. Rheumatologists SHOULD BE involved in management discussions 3. Potential shortages of sDMARDS and biologics @rheumnow https://t.co/sjQubD7mJL
3 hours 50 minutes ago
Patients with RA-ILD vs RA only: More likely to be older, male, white and RF positive. More likely to have COPD, Rheumatoid nodules, erosions, extraarticular disease,⬆️antiCCP,⬆️ESR & ⬆️DAS28(CRP), DAS28(ESR), CDAI & SDAI scores #EULAR2020 #eular20 https://t.co/OhI9NKpStE
Mario Pompermayer, MD pompermarioMD( View Tweet)
3 hours 50 minutes ago
SAPHO or PsA with CASPAR criteria? 1/3 of SAPHO pts meet PsA criteria (particularly active or hx of psoriasis). Interestingly, most with osteitis did not meet CASPAR criteria while those with synovitis did. #EULAR2020 @RheumNow #AB0738 https://t.co/G4p6OiocE3
Dr. Rachel Tate uptoTate( View Tweet)
3 hours 50 minutes ago
Congratulations from all of us at the BRC to Professor Paul Emery OBE for being awarded a Meritorious Award at EULAR 2020 #EULAR2020goesvirtual #EULAR2020 #FightingRMDsTogether https://t.co/z9T4AZ5P0u
NIHR Leeds BRC LeedsBRC( View Tweet)
3 hours 51 minutes ago
Guselkumab improved axial symptoms, over 24 weeks in active PsA patients with radiographic sacroiliitis. Post-hoc analysis from Discover1&2 studies (Prof P Helliwell). #OP0054. #EULAR2020, >GF

ARD & RMD Open ARD_BMJ( View Tweet)

3 hours 51 minutes ago
Can fatigue in RA vary by bDMARD used? IL-6 inhibitor treatment associated with attaining a low fatigue state (RR 1.20 vs csDMARDs). Given IL-6 secretion with HPA axis activation leads to fatigue/poor sleep, maybe something in this? RABBIT database OP0020 #EULAR2020 @RheumNow https://t.co/wzFcqdUMMV
David Liew drdavidliew( View Tweet)
3 hours 51 minutes ago
17,500 people connected at moment at the largest e-Congress I could imagine #EULAR2020 #EULAR2020goesvirtual

Loreto Carmona 🖖 carmona_loreto( View Tweet)

5 hours 8 minutes ago
You've got at least two good reasons not to forget about cardiovascular risk in ankylosing spondylitis. Traditional and inflammatory: it's the double whammy. Mike Nurmohamed from @Reade_020 #EULAR2020 @RheumNow https://t.co/GLH7wzvrLN
David Liew drdavidliew( View Tweet)
5 hours 8 minutes ago
Use Of TNFi Before, During And The 1stY after Pregnancy Among Women With RA: Most of the women with RA were not treated with TNFi before or in pregnancy. Women w. RA that continue Rx with TNFi through pregnancy were using certilozumab and etanercept #EULAR2020 @RheumNow Abs0302 https://t.co/bWKrpx1hx7
Dr Philip Robinson philipcrobinson( View Tweet)
5 hours 8 minutes ago
Increased cardiovascular risk in: - AS patients (adj HR 4.6 vs non-rheum controls) - longer disease duration of inflammatory rheum disease (7% per year) in a Spanish national multicentre project (CARMA) w 5y follow-up Martin Martinez OP0002 #EULAR2020 @RheumNow https://t.co/BffbfPfkj0
David Liew drdavidliew( View Tweet)
5 hours 11 minutes ago
Consensus Statement: Use Of Jakinib Therapy In Immune Mediated Inflammatory Diseases: A consensus statement from @drpnash and others. Abstract AB0352. #EULAR2020 @RheumNow https://t.co/5uqwFoUglS https://t.co/fIZPWGHAPx
Dr Philip Robinson philipcrobinson( View Tweet)
5 hours 11 minutes ago
Certolizumab Pegol: A Safe And Efficient Treatment In Patients With Uveitis During Pregnancy: Conclusion: CZP seems to be effective and safe in female patients with uveitis during pregnancy and neonates. Abstract AB1055 #EULAR2020 @RheumNow https://t.co/MzeZKBawTg
Dr Philip Robinson philipcrobinson( View Tweet)
5 hours 11 minutes ago
×